Anatara Trial Update
Filed with ASX · · 2 pages · English
Key points: Third Australian field trial terminated proactively Target Animal Safety Study continues, with no adverse effects reported Anatara remains on track to submit product registration dossier to the APVMA in Q3 2016 and launch Detach™ in Australia during 2017 th voluntarily terminated the third efficacy study in Australia, announced on 16 June 2016 for its lead product, Detach™, a non
Anatara Lifesciences Ltd on 6ix
Story so far
Earlier from Anatara Lifesciences
- Milestone and Market Update
- Zoetis Exclusive Research Evaluation and License Option
- Second Successful Detach Trial
Later from Anatara Lifesciences
- Anatara Expands Executive Team
- Successful Completion of Target Safety Study
- APVMA Submission Major Milestone Achieved
- R&D Tax Refund
- Investor Update
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences